
Plenary Sessions 1-3
Plenary Sessions are a showcase of submitted abstracts that the Scientific Program Chairs and organizers felt were the most representative of the most cutting edge science, reflect a diversity of topics and speakers, and was scored highly amongst the abstract reviewers (among other things).
Each Plenary Session will run for one hour in length and will offer both a ten (10) minute presentation and a two (2) minute Q&A period immediately after.
Plenary Session # 1, Thursday, May 19, 2022, 1:45 pm – 2:45 pm, Oregon Ballroom 201/202
1:45 pm.
Abstract # 082. In vivo tracking of clonal dynamics shows three phases of UV-induced skin carcinogenesis
1Cancer Biology and Evolution Program, Moffitt Cancer Center, Tampa, Florida, United States, 2Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, Florida, United States, 3Tumor Biology Department, Moffitt Cancer Center, Tampa, Florida, United States, 4Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States, 5Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida, United States
1:57 pm.
Abstract # 125. Dermal adipocyte precursor immune fibroblastic cells (IFCs) drive neutrophil recruitment in response to bacterial infection
Dermatology, University of California San Diego, La Jolla, California, United States
2:09 pm.
Abstract # 299. Oral difelikefalin improves itch and inflammatory biomarkers in atopic dermatitis subjects with moderate-to-severe pruritus
1Icahn School of Medicine at Mount Sinai, New York, New York, United States, 2Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy, 3The University of Mississippi, University, Mississippi, United States, 4Cara Therapeutics, Inc., Stamford, Massachusetts, United States
2:21 pm.
Abstract # 480. The spectrum of oligogenic variants in the RAS pathway in a PHACE cohort
1Stanford University School of Medicine, Stanford, California, United States, 2Ann and Robert H Lurie Children’s Hospital of Chicago, Chicago, Illinois, United States, 3Johns Hopkins Medicine, Baltimore, Maryland, United States, 4University of Wisconsin-Madison, Madison, Wisconsin, United States, 5University of California San Francisco School of Medicine, San Francisco, California, United States, 6Baylor College of Medicine, Houston, Texas, United States, 7NYU Langone Health, New York, New York, United States, 8Medical College of Wisconsin, Milwaukee, Wisconsin, United States, 9Harvard Medical School, Boston, Massachusetts, United States
2:33 pm.
Abstract # 544. Commensal induced accumulation of monocyte-derived cells in neonatal skin regulates long-term cutaneous type 17 inflammation.
Dermatology, University of California San Francisco, San Francisco, California, United States
————————————————————————————-
Plenary Session # 2, Friday, May 20, 2022, 1:45 pm – 2:45 pm, Oregon Ballroom 201/202
1:45 pm.
Abstract # 012. Tissue-specific manipulation of regulatory T cells reveals the skin to be a site of immune tolerance
1Dermatopathology, University of California San Francisco, San Francisco, California, United States, 2Dermatology, University of California San Francisco, San Francisco, California, United States, 3Universitat Salzburg Naturwissenschaftliche Fakultat, Salzburg, Salzburg, Austria, 4The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States, 5Harvard Medical School, Boston, Massachusetts, United States
1:57 pm.
Abstract # 140. Dissecting the cellular landscape of human skin across anatomical sites and in cutaneous malignancy through single cell transcriptomics and in situ sequencing
1King’s College London, London, United Kingdom, 2St John’s Institute of Dermatology, London, United Kingdom
2:09 pm.
Abstract # 195. Cutaneous toxicities associated with immune checkpoint inhibitors: an observational, pharmacovigilance study
1Department of Dermatology, Johns Hopkins Medicine, Baltimore, Maryland, United States, 2Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States
2:21 pm.
Abstract # 501. Meta-analyses of genome-wide association studies in multiethnic cohorts identify risk loci associated with hidradenitis suppurativa
1Division of Research, Kaiser Permanente Northern California, Oakland, California, United States, 2Department of Dermatology, Massachusetts General Hospital, Boston, Maryland, United States, 3Institute for human Genetics, University of California San Francisco, UCSF, San Francisco, California, United States, 423andMe, Sunnyvale, California, United States, 5Regeneron Genetics Center, Tarrytown, New York, United States
2:33 pm.
Abstract # 678. Efficacy of topical LXR agonist in the treatment of primary cicatricial alopecia in Scd1−/− mouse
1Department of Dermatology, Columbia University, New York, New York, United States, 2Department of Genetics and Development, Columbia University, New York, New York, United States
—————————————————————————————–
Plenary Session # 3, Saturday, May 21, 2022, 8:30 am – 9:30 am, Oregon Ballroom 201/202
8:30 am.
Abstract # 419. Glucose controls protein-protein interactions and epidermal differentiation
1Stanford University, Stanford, California, United States, 2University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States, 3UPMC, Pittsburgh, Pennsylvania, United States, 4VA Palo Alto Health Care System, Palo Alto, California, United States
8:42 am.
Abstract # 635. Reprogramming the tumor microenvironment by a second-generation recombinant modified vaccinia virus Ankara
1Memorial Sloan Kettering Cancer Center, New York, New York, United States, 2Weill Cornell Medicine, New York, New York, United States, 3Genvira Biosciences, Ottawa, Ontario, Canada, 4IMVAQ Therapeutics, Sammamish, Washington, United States
8:54 am.
Abstract # 741. Structural adaptations of epidermal stem cells to mechanical stress
Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
9:06 am.
Abstract # 760. Cellular landscape of the skin is primed by the oral epithelial regenerative transcription factor Pitx1 to promote wound healing
NIAMS, National Institutes of Health, Bethesda, Maryland, United States
9:18 am.
Abstract # 804. Fibroblast subpopulations orchestrate chronic inflammation in Hidradenitis Suppurativa
1Dept of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, United States, 2Div of Rheumatology, Dept of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States, 3Dept of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States, 4R&D Center, Almirall SA, Sant Feliu de Llobregat, Barcelona, Spain, 5Dept of Dermatology, University of California, Sacramento, California, United States